Abstinence and 'low-risk' consumption 1 year after the initiation of high-dose baclofen: A retrospective study among 'high-risk' drinkers

Alcohol and Alcoholism

Volumn 47, Issue 4, 2012, Pages 439-442

  Rigal, Laurent ^a   Alexandre Dubroeucq, Constance ^a   De Beaurepaire, Renaud ^b   Le Jeunne, Claire ^c   Jaury, Philippe ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Centre Hospitalier Paul Guiraud   (France)

^c HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG MEGADOSE; DRUG WITHDRAWAL; FATIGUE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INSOMNIA; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOMNOLENCE; VERTIGO;

ADULT; ALCOHOL DRINKING; ALCOHOLISM; BACLOFEN; FEMALE; GABA-B RECEPTOR AGONISTS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK; TEMPERANCE;

EID: 84864015589     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/ags028     Document Type: Article

References (17)

1. Addolorato G, Caputo F, Capristo E et al. (2002) Baclofen efficacy in reducing alcohol craving and intake: a preliminary doubleblind randomized controlled study. Alcohol Alcohol 37:504-8.
2. Addolorato G, Leggio L, Ferrulli A et al. (2007) Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet 370:1915-22.
3. Addolorato G, Leggio L, Cardone S et al. (2009) Role of the GABA(B) receptor system in alcoholism and stress: focus on clinical studies and treatment perspectives. Alcohol 43:559-63.
4. Agabio R, Marras P, Addolorato G et al. (2007) Baclofen suppresses alcohol intake and craving for alcohol in a schizophrenic alcohol-dependent patient: a case report. Alcohol Alcohol 42:575-81.
5. Ameisen O. (2005) Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician. Alcohol Alcohol 40:147-50.
6. Ameisen O. (2008) The End of My Addiction. New York: S Crichton Books.
7. Bucknam W. (2007) Suppression of symptoms of alcohol dependence and craving using high-dose baclofen. Alcohol Alcohol 42:158-60.
8. Dore GM, Lo K, Juckes L et al. (2011) Clinical experience with baclofen in the management of alcohol-dependent patients with psychiatric comorbidity: a selected case series. Alcohol Alcohol 46:714-20.
9. Enserink M. (2011) Addiction research. Anonymous alcoholic bankrolls trial of controversial therapy. Science 332:653.
10. European Medicines Agency. (2010) Guidelines for the development of medicinal products for the treatment of alcohol dependence. London: EMA.
11. Garbutt JC, Flannery B. (2007) Baclofen for alcoholism. Lancet 370:1884-5.
12. Garbutt JC, Kampov-Polevoy AB, Gallop R et al. (2010) Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial. Alcohol Clin Exp Res 34:1849-57.
13. O'Brien C. (2011) Addiction and dependence in DSM-V. Addiction 106:866-7.
14. Regier DA, Farmer ME, Rae DS et al. (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) Study. J Am Med Assoc 264:2511-8.
15. Reid MC, Fiellin DA, O'Connor PG. (1999) Hazardous and harmful alcohol consumption in primary care. Arch Intern Med 159:1681-9.
16. Smith CR, LaRocca NG, Giesser BS et al. (1991) High-dose oral baclofen: experience in patients with multiple sclerosis. Neurology 41:1829-31.
17. World Health Organization, Department of Mental Health and Substance Dependence, Noncommunicable Diseases and Mental Health Cluster. (2000) International Guide for Monitoring Alcohol Consumption and Related Harm. Geneva: WHO.